Andale , Khurt Rendelle .

HRN: 25-13-12  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2024
CEFUROXIME 750MG (VIAL)
12/25/2024
01/01/2025
IVTT
500mg
Q8
PCAP
Waiting Final Action 
12/25/2024
CEFTRIAXONE 1G (VIAL)
12/25/2024
01/01/2025
IV
1.3gms
OD
PCAP D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: